Paul Thorning

Crystec Pharma

Paul Thorningis a co-founder and Chief Executive Officer of CrystecPharma. He has over 25 years’ experience in the chemical and pharmaceutical industries in manufacturing, research, marketing, consultancy and senior executive roles. Paul was a former licensing director for AstraZeneca (member of Crestor acquisition team). Away from the pharmaceutical industry, Paul spent three years in Tanzania, Africa, where he was a programme director responsible for a team running hospitals, health programmes and community services for 140,000 Congolese refugees. Paul was subsequently appointed as Director of the Institute of Pharmaceutical Innovation at the University of Bradford, where he was actively involved in innovation in pharmaceutical sciences including the establishment of 3 innovation-based companies. Paul is a Non-Executive Director of Medilink North, and was appointed as the UK’s Focal Point for Health and Innovation with China. Paul speaks English, French, Italian and Swahili and intermediate Mandarin, holds an MBA and professional membership of the Institute of Marketing, and is a Fellow of the Institution of Mechanical Engineers.